Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

Twin Orphan Drug News
Motley Fool
Sat, 09/29/12 - 11:50 am
Tags:
Biomarin, orphan drugs, Peg-Pal, phenylketonuria, Kuvan
Biomarin: Four Clinical Trial Events to Watch Before Year End
TheStreet.com
Tue, 09/25/12 - 11:27 am
Tags:
Biomarin, BMN-111, GALNs, BMRN-763, Peg-Pal
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Tags:
Cell Therapeutics, Momenta, Onyx, Amag Pharmaceuticals, Biomarin, M&A, Celgene, Seattle Genetics, Galena Biopharma, ImmunoCellular, Amgen, Celldex, Dendreon, GSK, Vical, Oncothyreon, Biogen Idec, Merck KGaA, Bristol-Myers Squibb, Allos, Spectrum Pharmaceuticals, AstraZeneca
arclays Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight; Three Shots on Goal
Street Insider
Sat, 08/25/12 - 12:50 pm
Tags:
Biomarin
3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha
Tue, 08/21/12 - 11:33 am
Tags:
Biomarin, China Biologic, Anika
BioMarin Pharmaceuticals Inc: Today's Featured Health Care Laggard
The Street
Sat, 08/11/12 - 11:26 am
Tags:
Biomarin
Bio Buyouts
Motley Fool
Sun, 07/29/12 - 12:10 pm
Tags:
Seattle Genetics, Alexion, Regeneron, Biomarin, Vertex Pharmaceuticals, Idenix, Obagi Medical Products
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Fri, 07/27/12 - 11:55 am
Tags:
Vivus, Biomarin, Alkermes
Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model
Street Insider
Sun, 07/15/12 - 12:02 pm
Tags:
BMN-701, Biomarin, Pompe disease
GlaxoSmithKline rises on US and Europe drug submission, amid renewed talk of interest in Biomarin
Guardian, UK
Fri, 07/13/12 - 12:30 pm
Tags:
GSK, Biomarin, M&A
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thu, 06/28/12 - 12:49 pm
Tags:
GSK, Biomarin, M&A, Shire
BioMarin Higher as GSK Takeover Chatter Swirls
StreetInsider.com
Tue, 06/12/12 - 12:48 pm
Tags:
GSK, Biomarin, M&A
BioMarin Prices Share Offering - Analyst Blog
NASDAQ
Sun, 06/3/12 - 12:24 pm
Tags:
Biomarin
BioMarin to Raise Funds
Yahoo/Zacks
Thu, 05/31/12 - 06:15 pm
Tags:
Biomarin, stock offering
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Sat, 05/19/12 - 12:36 pm
Tags:
Halozyme, Novavax, Prolor, Valeant Pharmaceuticals, Myrexis, OPKO Health, Vertex Pharmaceuticals, Edwards Lifesciences, Medivation, Biomarin, Mylan
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Tags:
Bacterin, Biomarin, Athersys, Affymax, Acorda Therapeutics, Alexion
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Seeking Alpha
Sun, 05/13/12 - 01:36 pm
Tags:
Seattle Genetics, Biomarin, Jazz Pharmaceuticals, Illumina, Questcor Pharmaceuticals, Vivus
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Tags:
Biomarin, Amicus Therapeutics, Sanofi, Vertex
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Pharmabiz
Sat, 03/10/12 - 06:47 pm
Tags:
Biomarin, mucopolysaccharidosis, Morquio A Syndrome, BMN-110

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.